KOD
KOD
NASDAQ · Biotechnology

Kodiak Sciences Inc

$37.60
+0.55 (+1.48%)
As of Jun 24, 1:51 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target -66.0% upside
Low Target $8.80
Average Target $12.80
High Target $18.52
Current Price $37.60
Current
$37.60
Target
$12.80
$8.80 $12.80 avg $18.52
Scenario Analysis
Bear Case
$8.80
-76.6%
Low target
Base Case
$12.80
-66.0%
Avg target
Bull Case
$18.52
+-50.7%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$47.84
-21.4% from high
52-Week Low
$3.43
+996.2% from low
Target vs 52W High
$12.80
-73.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
Hold 44 50% $190.87 -45.7%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +189.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -7.8%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -65.2%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -32.8%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -45.0%